The hypoxic transcriptome of the retina: Identification of factors with potential neuroprotective activity

Advances in Experimental Medicine and Biology

Volumn 613, Issue , 2008, Pages 75-85

  Thiersch, Markus ^a   Raffelsberger, Wolfgang ^b   Frigg, Enrico ^b   Samardzija, Marijana ^b   Blank, Patricia ^b   Poch, Olivier ^b   Grimm, Christian ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCL 2 LIKE 11 PROTEIN; ENDOPHILIN; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN P21; PROTEIN PMAIP1; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTOME; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE NUMBER; GENE TARGETING; HYPOXIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETINA DEGENERATION; ANIMAL; ANOXIA; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL DEATH; DNA MICROARRAY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIGHT; METABOLISM; MOUSE MUTANT; RADIATION EXPOSURE; RETINA; TIME;

ANIMALS; ANOXIA; APOPTOSIS; CELL DEATH; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIGHT; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINA; TIME FACTORS;

EID: 38949105226     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74904-4_8     Document Type: Conference Paper

References (28)

1. Aviram, M., Rosenblat, M., Bisgaier, C.L., Newton, R.S., Primo-Parmo, S.L., and La Du, B.N. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101(8): 1581-1590.
2. Benjamini, Y. and Hochberg, Y. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc 57: 289-300.
3. Bocker-Meffert, S., Rosenstiel, P., Rohl, C., Warneke, N., Held-Feindt, J., Sievers, J., and Lucius, R. 2002. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci 43(6): 2021-2026.
4. Buck, M. and Chojkier, M. 2003. Signal transduction in the liver: C/EBPbeta modulates cell proliferation and survival. Hepatology 37(4): 731-738.
5. Cai, Z., Manalo, D.J., Wei, G., Rodriguez, E.R., Fox-Talbot, K., Lu, H., Zweier, J.L., and Semenza, G.L. 2003. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108(1): 79-85.
6. Dong, J.W., Zhu, H.F., Zhu, W.Z., Ding, H.L., Ma, T.M., and Zhou, Z.N. 2003. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 13(5): 385-391.
7. Draghici, S., Khatri, P., Bhavsar, P., Shah, A., Krawetz, S.A., and Tainsky, M.A. 2003a. Onto- Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res 31(13): 3775-3781.
8. Draghici, S., Khatri, P., Martins, R.P., Ostermeier, G.C., and Krawetz, S.A. 2003b. Global functional profiling of gene expression. Genomics 81(2): 98-104.
9. Draghici, S., Khatri, P., Shah, A., and Tainsky, M.A. 2003c. Assessing the functional bias of commercial microarrays using the onto-compare database. Biotechniques Suppl: 55-61.
10. Emerson, M.R., Nelson, S.R., Samson, F.E., and Pazdernik, T.L. 1999. A global hypoxia preconditioning model: neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats. Brain Res Brain Res Protoc 4(3): 360-366.
11. Fauser, S., Luberichs, J., and Schuttauf, F. 2002. Genetic animal models for retinal degeneration. Surv Ophthalmol 47(4): 357-367.
12. Gidday, J.M., Fitzgibbons, J.C., Shah, A.R., and Park, T.S. 1994. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168(1-2): 221-224.
13. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., and Reme, C.E. 2002. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8(7): 718-724.
14. Grimm, C., Wenzel, A., Stanescu, D., Samardzija, M., Hotop, S., Groszer, M., Naash, M., Gassmann, M., and Reme, C. 2004. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24(25): 5651-5658.
15. Ke, Q. and Costa, M. 2006. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70(5): 1469-1480.
16. Koury, M.J., Sawyer, S.T., and Brandt, S.J. 2002. New insights into erythropoiesis. Curr Opin Hematol 9(2): 93-100.
17. Mahyar-Roemer, M. and Roemer, K. 2001. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20(26): 3387-3398.
18. Maxwell, P. 2003. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 14(11): 2712-2722.
19. Miyashita, K., Itoh, H., Arai, H., Suganami, T., Sawada, N., Fukunaga, Y., Sone, M., Yamahara, K., Yurugi-Kobayashi, T., Park, K., Oyamada, N., Sawada, N., Taura, D., Tsujimoto, H., Chao, T.H., Tamura, N., Mukoyama, M., and Nakao, K. 2006. The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology 147(4): 1642-1653.
20. Naumann, U., Weit, S., Wischhusen, J., and Weller, M. 2001. Diva/Boo is a negative regulator of cell death in human glioma cells. FEBS Lett 505(1): 23-26.
21. Samardzija, M., Wenzel, A., Naash, M., Reme, C.E., and Grimm, C. 2006. Rpe65 as a modifier gene for inherited retinal degeneration. Eur J Neurosci 23(4): 1028-1034.
22. Sharp, F.R. and Bernaudin, M. 2004. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5(6): 437-448.
23. Song, Q., Kuang, Y., Dixit, V.M., and Vincenz, C. 1999. Boo, a novel negative regulator of cell death, interacts with Apaf-1. Embo J 18(1): 167-178.
24. Wenzel, A., Grimm, C., Samardzija, M., and Reme, C.E. 2005. Molecular mechanisms of lightinduced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 24(2): 275-306.
25. Wenzel, A., Reme, C.E., Williams, T.P., Hafezi, F., and Grimm, C. 2001. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J Neurosci 21(1): 53-58.
26. Yu, D.Y. and Cringle, S.J. 2005. Retinal degeneration and local oxygen metabolism. Exp Eye Res 80(6): 745-751.
27. Zaman, K., Ryu, H., Hall, D., O 'Donovan, K., Lin, K.I., Miller,M.P., Marquis, J.C., Baraban, J.M., Semenza, G.L., and Ratan, R.R. 1999. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 19(22): 9821-9830.
28. Zhang, S.X. and Ma, J.X. 2007. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26(1): 1-37.